Rps Infectious Diseases - PA Berks, Reading 19611

Rps Infectious Diseases entered the industry of Health Practitioners in 1990 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 6211110, which describes it as a Health Practitioners. For further clarification, the SIC classifies this business under the code 8049 and described it as a Health Practitioners. The business provides service to the B2B market.

To acquire more information, please contact Laya Komlodi, Office Manager by calling (610) 988-4630 during business hours. You can also write to the business’ Single Location at 301 South 7th Avenue # 130, Reading, Pennsylvania PA 19611. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Rps Infectious Diseases
Representative: Laya Komlodi, Office Manager
Place of Business: 301 South 7th Avenue # 130, Reading, PA 19611
Contact Number: (610) 988-4630
Type of Service: Health Practitioners
SIC Number: 8049
NAICS Number: 6211110
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 1990
Income/Year: $1.000.000 to $2.499.999
Laborers: 1 to 4
Share This Company:

Rps Infectious Diseases is a company operating from Berks, Pennsylvania providing professional Health Practitioners and relevant B2B variables. It was founded in 1990 and registered with the SIC code 8049 as Health Practitioners, and with the NAICS code 6211110 as Health Practitioners.

With a current employee count of 1 to 4, Rps Infectious Diseases has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Laya Komlodi, Office Manager at (610) 988-4630 for related queries, or to locate its Single Location using the coordinates 40.33063,-75.95216.

The Single Location can also be found at the street address 301 South 7th Avenue # 130 in Reading, Pennsylvania 19611 and can be engaged online through the company website at , the company Twitter , and Facebook page .